Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
Classifica tra le azioni #10859
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Prezzo delle azioni
$25.15
Capitalizzazione di mercato
$253.18M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-12.08%
Paese
FR
Scambia Eurobio Scientific Société anonyme (ALERS)

Categoria

Utile per Eurobio Scientific Société anonyme (ALERS)
Utile nel Dec 2025 TTM: $9.16M
Secondo gli ultimi rapporti finanziari di Eurobio Scientific Société anonyme, gli utili attuali della società sono $9.16M. Nel 2023, la società ha registrato un utile di $7.71M, una diminuzione rispetto a agli utili del 2022, che erano di $31.84M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Eurobio Scientific Société anonyme dal 2007 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $9.16M 39.69%
2024 $6.56M -15.00%
2023 $7.71M -75.78%
2022 $31.84M -60.74%
2021 $81.09M -17.68%
2020 $98.51M 53,765.43%
2019 $182.88K -105.65%
2018 $-3.24M -70.90%
2017 $-11.13M 28.22%
2016 $-8.68M 23.50%
2015 $-7.03M -10.09%
2014 $-7.82M -20.26%
2013 $-9.81M 10.74%
2012 $-8.86M -16.61%
2011 $-10.62M -12.50%
2010 $-12.14M -9.16%
2009 $-13.36M -12.97%
2008 $-15.35M 31.03%
2007 $-11.72M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$8.14B 88,757.50%
US
$4.60B 50,132.83%
US
$6.14B 66,919.05%
IE
$3.74B 40,763.31%
US
$1.30B 14,074.39%
US